Loading…
Based on limited metadata, this warning letter was issued to Advanced Botanical Consulting & Testing Inc (dba ABC Testing) on June 4, 2019, regarding drug products. While the specific violations cannot be determined without access to the full letter text, the warning indicates FDA regulatory concerns related to drug manufacturing, testing, or compliance. The letter falls under FDA's drug product jurisdiction, though the issuing office is not specified in the available metadata.